Abstract
Pelger-Huet anomaly (PHA) is a benign hematological anomaly that is characterized by impaired lobulation of neutrophils with a coarse nuclear chromatin. Skeletal abnormalities may accompany this anomaly. Autosomal recessive deafness-4 (DFNB4) with enlarged vestibular aqueduct (EVA) comprises a phenotypic spectrum of sensorineural hearing loss (SNHL). We report a case with SNHL, multiple skeletal anomalies including osteochondroma, developmental delay, and PHA. Molecular studies revealed a heterozygous pathogenic variant in the LBR gene and a homozygous likely pathogenic variant in the SLC26A4 gene. Due to these 2 variants, he was diagnosed with PHA and DFNB4 with EVA. If goiter develops, DFNB4 with EVA is named Pendred syndrome (PDS), so the patient will be followed up for this condition, and in the current literature, there is no case with PDS and PHA co-existence either. PHA may be accompanied by multiple skeletal abnormalities. In our case, there is also concomitance with osteochondroma. Although these are independent and distinct diagnoses, we present this case due to the concomitance of these situations.
References
1.
Adzhubei
IA
, Schmidt
S
, Peshkin
L
, Ramensky
VE
, Gerasimova
A
, Bork
P
, A Method and Server for Predicting Damaging Missense Mutations
. Nat Methods
. 2010
;7
(4
):248
–9
.2.
Borovik
L
, Modaff
P
, Waterham
HR
, Krentz
AD
, Pauli
RM
. Pelger-Huet Anomaly and a Mild Skeletal Phenotype Secondary to Mutations in LBR
. Am J Med Genet A
. 2013
;161A
(8
):2066
–73
.3.
Carvalho
MDF
, Carvalho
KM
, Carvalho
IF
, Cavalcanti
DP
, Carvalho
EDF
. Case report of a mild skeletal phenotype secondary to mutations in LBR gene. (Poster Abstract 914T)
. 67th Annual Meeting of The American Society of Human Genetics, October 17–21, 2017 in Orlando, Florida
. Available from: https://www.ashg.org/wp-content/uploads/2019/10/2017-Poster-Abstracts.pdf.4.
Choi
BY
, Kim
HM
, Ito
T
, Lee
KY
, Li
X
, Monahan
K
, Mouse model of enlarged vestibular aqueducts defines temporal requirement of Slc26a4 expression for hearing acquisition
. J Clin Invest
. 2011
;121
:4516
–25
. 5.
Dawson
PA
, Markovich
D
. Pathogenetics of the Human SLC26 Transporters
. Curr Med Chem
. 2012
;12
(4
):385
–96
. 6.
Fugazzola
L
, Cerutti
N
, Mannavola
D
, Crino
A
, Cassio
A
, Gasparoni
P
, Differential diagnosis between Pendred and pseudo-Pendred syndromes: clinical, radiologic, and molecular studies
. Pediatr Res
. 2002 Apr
;51
(4
):479
–84
. 7.
Gastearena
J
, Orue
MT
, Perez Equiza
E
. Anomalia de pelger huet homocigota. A Proposito de un caso
. Sangre
. 1982
;27
(6
):1079
–81
.8.
Gettelfinger
JD
, Dahl
JP
. Syndromic Hearing Loss: A Brief Review of Common Presentations and Genetics
. J Pediatr Genet
. 2018
;7
(01
):1
–8
. 9.
Hoffmann
K
, Dreger
CK
, Olins
AL
, Olins
DE
, Shultz
LD
, Lucke
B
, Mutations in the Gene Encoding the Lamin B Receptor Produce an Altered Nuclear Morphology in Granulocytes (Pelger-Huët Anomaly)
. Nat Genet
. 2002
;31
(4
):410
–4
.10.
Koohiyan
M
. A Systematic Review of SLC26A4 Mutations Causing Hearing Loss in the Iranian Population
. Int J Pediatr Otorhinolaryngol
. 2019
;125
:1
–5
.11.
McGinnis
S
, Madden
TL
. BLAST: At the Core of a Powerful and Diverse Set of Sequence Analysis Tools
. Nucleic Acids Res
. 2004
;32
(Web Server issue
):W20
–5
.12.
Mey
K
, Muhamad
AA
, Tranebjærg
L
, Rendtorff
ND
, Rasmussen
SH
, Bille
M
, Association of SLC26A4 Mutations, Morphology, and Hearing in Pendred Syndrome and NSEVA
. Laryngoscope
. 2019
;129
(11
):2574
–9
.13.
Nykamp
K
, Anderson
M
, Powers
M
, Garcia
J
, Herrera
B
, Ho
Y-Y
, Sherloc: A Comprehensive Refinement of the ACMG-AMP Variant Classification Criteria
. Genet Med
. 2017
;19
(10
):1105
–17
.14.
Olins
AL
, Ernst
A
, Zwerger
M
, Herrmann
H
, Olins
DE
. An in Vitro Model for Pelger-Huët Anomaly; Stable Knockdown of Lamin b Receptor in Hl-60 Cells
. Nucleus
. 2010a
;1
(6
):506
–12
.15.
Olins
AL
,Rhodes
G
, Welch
DB
, Zwerger
M
, Olins
DE
. Lamin B Receptor: Multi-Tasking at the Nuclear Envelope
. Nucleus
. 2010b
;1
(1
):53
–70
.16.
Oosterwijk
JC
, Mansour
S
, Van Noort
G
, Waterham
HR
, Hall
CM
, Hennekam
RCM
. Congenital Abnormalities Reported in Pelger-Huët Hornozygosity as Compared to Greenberg/HEM Dysplasia: Highly Variable Expression of Allelic Phenotypes
. J Med Genet
. 2003
;40
(12
):937
–41
.17.
Park
HJ
, Lee
SJ
, Jin
HS
, Lee
JO
, Go
SH
, Jang
HS
, Genetic Basis of Hearing Loss Associated with Enlarged Vestibular Aqueducts in Koreans
. Clin Genet
. 2005
;67
(2
):160
–5
. 18.
Posey
JE
, Harel
T
, Liu
P
, Rosenfeld
JA
, James
RA
, Coban Akdemir
ZH
, Resolution of Disease Phenotypes Resulting from Multilocus Genomic Variation
. N Engl J Med
. 2017
;376
(1
):21
–31
. 19.
Pourahmadiyan
A
, Alipour
P
, Fattahi
N
, Kasiri
M
, Rezaeian
F
, Taghipour-Sheshdeh
A
, A Pathogenic Variant in SLC26A4 Is Associated with Pendred Syndrome in a Consanguineous Iranian Family
. Int J Audiol
. 2019
;58
(10
):628
–34
.20.
Scott
DA
, Wang
R
, Kreman
TM
, Andrews
M
, McDonald
JM
, Bishop
JR
, Functional Differences of the PDS Gene Product Are Associated with Phenotypic Variation in Patients with Pendred Syndrome and Non-Syndromic Hearing Loss (DFNB4)
. Hum Mol Genet
. 2000
;9
(11
):1709
–15
.21.
Smith
N
, U-King-Im
JM
, Karalliedde
J
. Delayed Diagnosis of Pendred Syndrome
. BMJ Case Rep
. 2016
;2016
:bcr2016215271
.22.
Speeckaert
MM
, Verhelst
C
, Koch
A
, Speeckaert
R
, Lacquet
F
. Pelger-Huët Anomaly: A Critical Review of the Literature
. Acta Haematol
. 2009
;121
(4
):202
–6
.23.
Stevens
G
, Flaxman
S
, Brunskill
E
, Mascarenhas
M
, Mathers
CD
, Finucane
M
, Global and Regional Hearing Impairment Prevalence: An Analysis of 42 Studies in 29 Countries
. Eur J Public Health
. 2013
;23
(1
):146
–52
. 24.
Tsukamoto
K
, Suzuki
H
, Harada
D
, Namba
A
, Abe
S
, Usami
S
, Distribution and frequencies of PDS (SLC26A4) mutations in Pendred syndrome and nonsyndromic hearing loss associated with enlarged vestibular aqueduct: a unique spectrum of mutations in Japanese
. Eur J Hum Genet
. 2003
;11
:916
–22
. 25.
Wémeau
JL
, Kopp
P
. Pendred Syndrome
. Best Pract Res Clin Endocrinol Metab
. 2017
;31
(2
):213
–24
.© 2022 S. Karger AG, Basel
2022
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
